Moreover, overexpressing miR-182 in mesenchymal cancer cells decreased the expression of Vimentin (Figure 3B), while suppressing miR-182 in epithelial cancer cells reduced E-cadherin expression (Figure 3C). This evidence concerns the gene VIM and cancer.